• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
  
• Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
  

PubMed=7814883; DOI=10.4049/jimmunol.154.2.772
Takahashi T., Chapman P.B., Yang S.Y., Hara I., Vijayasaradhi S., Houghton A.N.
Reactivity of autologous CD4+ T lymphocytes against human melanoma Evidence for a shared melanoma antigen presented by HLA-DR15.
J. Immunol. 154:772-779(1995)

PubMed=9598804; DOI=10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N
Walker G.J., Flores J.F., Glendening J.M., Lin A.H.-T., Markl I.D.C., Fountain J.W.
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
Genes Chromosomes Cancer 22:157-163(1998)